Healthcare IT Today

APRIL 25, 2024

The company is developing improved data federation tools along with various machine learning algorithms in the areas of oncology and cardiometabolic disease. The US has the highest rate of avoidable cancer and cardiometabolic-related deaths among any high-income country. “At

Drug Development 106

Drug Development healthcare technology Health IT Healthcare IT 106

Healthcare IT Today

NOVEMBER 7, 2023

A recent Deloitte study estimates the average cost of developing a single new drug at $2.3 This ML-driven adaptive process can significantly accelerate the clinical drug development process and increase certainty along the way, resulting in more efficient, targeted, and ultimately more successful clinical trials.

Drug Development 63

Drug Development BioTech Pharmaceuticals Health IT 63

Healthcare IT Today

JANUARY 8, 2024

We asked the Healthcare IT Today community to submit their predictions and we received a wide ranging set of responses that we grouped into a number of themes. Riccardo Butta, President of the Americas at Stevanato Group In 2024, we can expect progress around men’s health, specifically in prostate cancer.

Health IT 87

Health IT Drug Development Pharmaceuticals BioTech 87

Healthcare IT Today

JANUARY 9, 2023

We asked the Healthcare IT Today community to submit their predictions and we received a wide ranging set of responses that we grouped into a number of themes. Kimberly Powell, Vice President of Healthcare at NVIDIA. Can they see changes locally in the tumor microenvironment that indicate the drug is having a biology effect?

Health IT 94

Health IT Pharmaceuticals Drug Development Life Science 94

Healthcare IT Today

MAY 22, 2023

“We are excited to have the support of such a strong group of investors who share our mission of unlocking the power of data to improve health,” said Sundeep Bhan, CEO at Prognos Health.

Life Science 59

Life Science Drug Development Health IT Healthcare IT 59

Healthcare IT Today

NOVEMBER 14, 2022

Latest Round of Investment in the Family Engagement Technology Company Led by Bradford Whitmore and Mountain Group Partners, with Participation by SeedtoB Capital and the Rash Family Office. The Series B financing was led by Brad Whitmore and Mountain Group Partners (MGP), with participation from SeedtoB Capital and the Rash Family Office.

Life Science 95

Life Science HIPAA Drug Development healthcare technology 95

Healthcare IT Today

OCTOBER 6, 2023

The funding enables Atropos Health to accelerate commercial and development opportunities outside the U.S.,

Life Science 105

Life Science Drug Development Pharmaceuticals Health IT 105